ArticleInvestigational new drugs2014

A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.

Silvia Valtorta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.